Organization Profile

You just read:

Hepatitis C cure rate of 94% achieved in patients post-liver transplant and up to 94% in those with advanced cirrhosis (Child-Pugh Class A and B) following 12-week, oral treatment with combination daclatasvir and sofosbuvir once daily, plus ribavirin, in ALLY-1 trial

News provided by

Bristol-Myers Squibb Canada

Apr 29, 2015, 05:59 ET